TECH - Bio-Techne - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09073M1045

Reagents, Instruments, Services, Diagnostics, Genomics, Assays, Controls

Bio-Techne Corporation is a leading life science company that develops, manufactures, and sells a wide range of reagents, instruments, and services for research, diagnostics, and bioprocessing markets globally. The company operates through two main business segments: Protein Sciences and Diagnostics and Genomics.

The Protein Sciences segment is focused on developing and manufacturing biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. These reagents include cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers advanced proteomic analytical tools, such as automated western blot and multiplexed ELISA workflow, which consist of manual and automated protein analysis instruments and immunoassays. These tools enable researchers to quantify proteins in various biological fluids with high accuracy and efficiency.

The Diagnostics and Genomics segment develops and manufactures a broad range of diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. The segment also offers innovative exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Additionally, the segment sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications.

Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. The company has undergone significant transformations over the years, including a name change from Techne Corporation to Bio-Techne Corporation in November 2014. Today, the company is a leading player in the life science industry, with a strong commitment to innovation, quality, and customer satisfaction. For more information, please visit the company's website at https://www.bio-techne.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for TECH - Bio-Techne  - Stock Price & Dividends

TECH Stock Overview

Market Cap in USD 11,702m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1989-02-09

TECH Stock Ratings

Growth 5y 25.0
Fundamental 54.3
Dividend 31.4
Rel. Performance vs Sector -0.62
Analysts 4.33/5
Fair Price Momentum 64.83 USD
Fair Price DCF 37.14 USD

TECH Dividends

Dividend Yield 12m 0.46%
Yield on Cost 5y 0.65%
Dividends CAGR 5y 0.00%
Payout Consistency 96.0%

TECH Growth Ratios

Growth 12m 10.98%
Growth Correlation 12m 55.4%
Growth Correlation 3m -18.7%
CAGR 5y 7.16%
CAGR/Mean DD 5y 0.29
Sharpe Ratio 12m 0.17
Alpha vs SP500 12m -27.27
Beta vs SP500 5y weekly 1.00
ValueRay RSI 21.43
Volatility GJR Garch 1y 33.56%
Price / SMA 50 -5.33%
Price / SMA 200 -4.39%
Current Volume 930.3k
Average Volume 20d 778.1k

External Links for TECH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of TECH stocks?
As of October 18, 2024, the stock is trading at USD 70.15 with a total of 930,295 shares traded.
Over the past week, the price has changed by -3.88%, over one month by -6.81%, over three months by -10.30% and over the past year by +10.00%.
What are the forecast for TECH stock price target?
According to ValueRays Forecast Model, TECH Bio-Techne will be worth about 71.8 in October 2025. The stock is currently trading at 70.15. This means that the stock has a potential upside of +2.37%.
Issuer Forecast Upside
Wallstreet Target Price 82.8 18.0
Analysts Target Price 101 44.0
ValueRay Target Price 71.8 2.37